VYT — Vytrus Biotech SA Share Price
Last trade - 00:00- €24.17m
- €23.42m
- €5.04m
- 87
- 17
- 91
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.31 | ||
| Price to Tang. Book | 7.51 | ||
| Price to Free Cashflow | 37.76 | ||
| Price to Sales | 4.79 | ||
| EV to EBITDA | 13.51 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.17% | ||
| Return on Equity | 16.23% | ||
| Operating Margin | 19.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.7 | 2.8 | 3.68 | 3.74 | 5.04 | n/a | n/a | 32.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +143.27 | +34.87 | -10 | +72.43 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vytrus Biotech SA, formerly Phyture Biotech SL, is Spain-based company principally engaged in the biotechnology industry. The Company develops high added value natural active ingredients on an industrial scale and provides ingredients and recombinant proteins for its use in the cosmetics and pharmaceutical sectors. The Company’s technology is based on using plant cell cultures to produce bioactive molecules. The Company obtains plant cells, known as Plant Stem Cell technology, which is applicable for cosmetics. Vytrus Biotech specifically target dermo-cosmetics as well as veterinary medicine, functional food and other pharmaceuticals, generating savings of more than 99% in natural resources.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 2nd, 2009
- Public Since
- March 24th, 2022
- No. of Employees
- 37
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- Madrid Stock Exchange
- Shares in Issue
- 7,554,521
- Address
- Sant Gaieta 121, 2nd, TERRASSA, 08221
- Web
- https://www.vytrus.com/
- Phone
- +34 931278106
- Auditors
- RSM Audit Services Limited
Upcoming Events for VYT
Similar to VYT
Alquiber Quality SA
Madrid Stock Exchange
Better Consultants SA
Madrid Stock Exchange
Catenon SA
Madrid Stock Exchange
Ev Motors SA
Madrid Stock Exchange
Fomento de Construcciones y Contratas SA
Madrid Stock Exchange
FAQ
As of Today at 24:03 UTC, shares in Vytrus Biotech SA are trading at €3.20. This share price information is delayed by 15 minutes.
Shares in Vytrus Biotech SA last closed at €3.20 and the price had moved by +39.13% over the past 365 days. In terms of relative price strength the Vytrus Biotech SA share price has outperformed the FTSE Global All Cap Index by +35.65% over the past year.
There is no consensus recommendation for this security.
Find out moreVytrus Biotech SA does not currently pay a dividend.
Vytrus Biotech SA does not currently pay a dividend.
Vytrus Biotech SA does not currently pay a dividend.
To buy shares in Vytrus Biotech SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €3.20, shares in Vytrus Biotech SA had a market capitalisation of €24.17m.
Here are the trading details for Vytrus Biotech SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: VYT
Based on an overall assessment of its quality, value and momentum Vytrus Biotech SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vytrus Biotech SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +43.96%.
As of the last closing price of €3.20, shares in Vytrus Biotech SA were trading +33.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vytrus Biotech SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €3.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Vytrus Biotech SA's directors